Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
07/2010
07/01/2010CA2740928A1 New retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties
06/2010
06/30/2010EP2202222A2 Indene derivatives, their preparation and use as medicaments
06/30/2010EP2201946A1 Pai-1 production inhibitor
06/30/2010EP2200970A1 Aldehydes containing hydroxyl groups
06/30/2010EP1735270B1 Diamino alcohols and their use as renin inhibitors
06/30/2010CN101765585A antibacterial agents
06/30/2010CN101759668A Cinnamamide derivative and application as cerebral nerve protective agent
06/30/2010CN101759667A Preparation method of novel antidepressant moclobemide
06/30/2010CN101759666A Preparation method of pinaverium bromide
06/30/2010CN101759665A Substituent phenylpiperazine aryl alkanol derivant and application thereof in preparing analgesics
06/30/2010CN101759633A Reagents for analyzing N-linked sugar chain
06/30/2010CN101759604A Guanidyl substitutional tetracycline derivative
06/30/2010CN101759599A Tetracycline compound with amino isonitroso
06/30/2010CN101759598A Tetracycline compound with amino acid amidine
06/29/2010US7745626 Stereoselective alkylation of chiral 2-methyl-4-protected piperazines
06/29/2010US7745465 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease
06/29/2010US7745464 heterocyclic compounds that bind to disease-related proteins, used for treating and modulating disorders associated with hyperproliferation, such as cancer
06/29/2010US7745463 useful for the treatment of human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS)
06/29/2010US7745456 2,5-bis{[alkyl(or aryl)imino]aminophenyl}furans and thiophenes; "reversed" amidines; DNA-binding affinities; microbiocide; mycobacterial, fungal, protozoal infection; Mycobacterium tuberculosis, Trypanosoma spp., Candida albicans, Aspergillus spp., Cryptosporidium parvum, Giardia lamblia, Plasmodium spp.
06/29/2010US7745451 2,3-Difluoro-benzyl)-[6-(5-methyl-pyridin-2-yl)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-yl]-amine, useful for the prevention and treatment of pain, inflammation, cognitive disorders, anxiety and depression in humans
06/29/2010US7745441 Urokinase inhibitors
06/29/2010US7745439 Indene derivatives and process for the preparation thereof
06/29/2010US7745436 Disalt inhibitors of IL-12 production
06/29/2010US7745413 Collection of traceable compounds and uses thereof
06/29/2010CA2442885C Sulphones which modulate the action of gamma secretase
06/29/2010CA2442881C New process for the industrial synthesis of the tetraesters of 5-[bis(carboxymethyl)amino]-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis ofbivalent salts of ranelic acid and their hydrates
06/24/2010WO2010071567A1 (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
06/24/2010WO2010070615A1 Cysteine protease inhibitors
06/24/2010WO2010070371A1 Process for the preparation of piperazine derivatives
06/24/2010WO2010070370A1 Process for the preparation of piperazine compounds and hydrochloride salts thereof
06/24/2010WO2010070369A1 Piperazine salt and a process for the preparation thereof
06/24/2010WO2010069758A1 Polymerizable photoinitiators and radiation curable compositions
06/24/2010US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160331 Novel carbamoyloxy arylalkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
06/24/2010US20100160289 Sulfonamides as trpm8 modulators
06/24/2010US20100158996 Ester compound and medical use thereof
06/24/2010US20100158818 Antimicrobial n-chlorinated compositions
06/24/2010CA2746990A1 (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
06/24/2010CA2744888A1 Cysteine protease inhibitors
06/24/2010CA2744073A1 Process for the preparation of piperazine compounds and hydrochloride salts thereof
06/24/2010CA2743924A1 Piperazine salt and a process for the preparation thereof
06/23/2010EP2199282A1 Amide compound
06/23/2010EP2199273A1 Polymerizable photoinitiators and radiation curable compositions
06/23/2010EP2197830A2 Method for producing amines from sugar alcohols
06/23/2010CN1906155B Novel hydroxamic acid ester derivant and pharmaceutical use thereof
06/23/2010CN101754958A Method for the production of highly pure 2,4'-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions containing the same, and agent formulations containing tolperisone
06/23/2010CN101747295A Methanesulfonic acid cinepazide crystal form and preparation method
06/23/2010CN101747294A Method for purifying N-(2,6-xylyl)-2-(1-piperazinyl)acetamide
06/23/2010CN101747293A Naftopidil preparing method
06/23/2010CN101747292A Benzoylguanidine-trimetazidine conjugate, as well as preparation method and medical application thereof
06/23/2010CN101747243A Ionic liquid prepared through diimine (vikane) and (perfluoroalkglsulfonyl fluorosulfonyl group) imine alkali salt
06/23/2010CN101161645B Urea derivatives as well as preparation method and uses thereof
06/22/2010US7741480 Process for the preparation of linezolid and related compounds
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010US7741323 6-methoxy-1-(trans-methylimino-N-oxy)-3-phenyl-1H-indene-2-carboxylate ethyl ester, used for selectively modulating the activities of peroxisome proliferator activated receptors; excellent effect in lowering both blood glucose and insulin levels; side effect reduction
06/22/2010US7741318 used for treating central nervous system diseases such as depression, cognitive diseases and neurodegenerative diseases such as Parkinson's disease, alzheimer's disease or psychoses, and stroke
06/22/2010US7741316 Pharmacological uses of azetidine derivatives
06/22/2010CA2541131C Derivatives of piperazine, process for their preparation and pharmaceutical compositions containing them
06/22/2010CA2441398C Lipid lowering biphenylcarboxamides
06/22/2010CA2420996C Substituted heterocyclic compounds for treating multidrug resistance
06/22/2010CA2315715C Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
06/17/2010WO2010066010A1 Process for the preparation of asymmetrical bis(thiosemicarbazones)
06/17/2010US20100152220 Indene derivatives as pharmaceutical agents
06/17/2010US20100150836 Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging
06/17/2010CA2746070A1 Process for the preparation of asymmetrical bis(thiosemicarbazones)
06/16/2010EP2195293A2 Cycloptopyl amide derivatives
06/16/2010CN1993337B Method for improving a piperazine colour stability
06/16/2010CN1839124B Succinate and malonate salt of trans-4-(1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament
06/16/2010CN101735173A Heavy metal chelating agent and preparation method thereof
06/16/2010CN101735172A Cinepazide monohydrate, crystal forms and preparation method thereof
06/16/2010CN101735113A Urea derivatives, preparation method and use thereof
06/16/2010CN101735102A Method for synthesizing 2,2-disubstituted acetaldehyde hydrazone at room temperature under low pressure by taking acetylene as raw material
06/16/2010CN101735090A Process for preparing secondary amides by carbonylation of a corresponding tertiary amine
06/16/2010CN101735079A Derivative of beta-amine methyl cyclopentanol and cyclopentyl ester, preparation method and application thereof
06/16/2010CN101177420B Method for intermittent azeotropic rectifying separating N-ethylpiperazine-ethanolamine
06/15/2010US7737286 α-Hydroxy-benzeneacetic acid derivatives, and compounds having two 5-membered latone rings fused to central cyclohexa-1,4-diene nucleus based upon the same, and uses of the compounds
06/15/2010US7737283 Urea substituted with a 5 member nitrogen-containing ring; biological conjugated drug used to modulate of the activation state of p38 kinase protein; antiinflammatory agents; rheumatoid arthritis, asthma, sepsis, toxic shock syndrome, adult respiratory distress syndrome, stroke, reperfusion injury
06/15/2010US7737143 such as 6-(1H-Benzimidazol-1-yl)-N-benzylpyrazin-2-amine, used as antidiabetic, anticarcinogenic and antiarthritic agents or for treating autoimmune diseases
06/15/2010US7737142 (Thio) carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists
06/15/2010CA2441309C Biguanide derivatives
06/15/2010CA2328440C Heterocyclically substituted amides used as calpain inhibitors
06/10/2010WO2010065801A1 Amine substituted piperazine melanocortin receptor-specific compounds
06/10/2010WO2010065512A2 Compounds for treating proliferative disorders
06/10/2010WO2010064631A1 Photobase generator
06/10/2010WO2010063774A1 Novel 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
06/10/2010WO2010063403A2 Radioisotope-labeled lysine and ornithine derivatives, their use and processes for their preparation
06/10/2010WO2010044940A3 2,5-linked polyfluorenes for optoelectronic devices
06/10/2010WO2010043976A3 Highly pure ranolazine or a pharmaceutically acceptable salt thereof
06/10/2010WO2009147170A3 Drug combinations comprising a dgat inhibitor and a ppar-agonist
06/10/2010US20100145048 Compounds for the treatment of inflammatory disorders
06/10/2010US20100144720 Inhibitors of human tumor-expressed ccxckr2
06/10/2010US20100144588 Proton acceptor iminium/carbocation-type coupling agents
06/10/2010US20100143455 Triazole antifungal agents
06/10/2010CA2745364A1 Radioisotope-labeled lysine and ornithine derivatives, their use and processes for their preparation
06/10/2010CA2745065A1 Compounds for treating proliferative disorders
06/10/2010CA2744711A1 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
06/10/2010CA2744708A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
06/10/2010CA2742709A1 Novel 4- (azacycloalkyl) benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
06/09/2010EP2049508B1 N-hydroxy-3-(4-{3-phenyl-3-oxo-propenyl}-phenyl)-acrylamide derivatives and related compounds as histone deacetylase inhibitors for the treatment of cancer
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 341